3 years ago
FATE
AnalystsRobert BurnsRobert Burns's Stock Forecasts
AnalystsRobert Burns
Sectors:
Industries:
Analyst Ranking
Bottom 1%
#5093 out of 5095 analysts
Average Return
-8.3%
Win Rate
36%192 out of 531
Risk vs Reward
Poor
Good
Robert Burns's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Tango Therapeutics IncTNGX | +460.45% | $1.34 | $7.51 | 2025-04-13 - 2025-11-05 | Buy |
Immunomedics IncIMMU | +342.36% | $18.91 | $83.65 | 2020-04-06 - 2020-09-14 | Buy |
Adc Therapeutics SaADCT | +287.50% | $0.80 | $3.10 | 2023-09-18 - 2024-09-18 | Buy |
Turning Point Therapeutics IncTPTX | +208.74% | $35.13 | $108.46 | 2020-03-16 - 2021-03-17 | Buy |
Revolution Medicines IncRVMD | +201.93% | $19.65 | $59.33 | 2023-11-13 - 2024-11-12 | Buy |
Robert Burns Analyst Color
Get additional color on Robert Burns's coverage of popular stocks
Robert Burns's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Exelixis IncEXEL | 11 | Buy | $49.00 | +21.38% | Maintains | a day ago |
Caribou Biosciences IncCRBU | 15 | Buy | $9.00 | +310.96% | Maintains | a day ago |
Cogent Biosciences IncCOGT | 13 | Buy | $21.00 | +45.63% | Reiterates | 2 days ago |
Macrogenics IncMGNX | 19 | Hold | $2.00 | +38.89% | Reiterates | 3 days ago |
Fate Therapeutics IncFATE | 7 | Buy | $5.00 | +358.72% | Upgrades | 6 days ago |
Repare Therapeutics IncRPTX | 19 | Buy | $3.00 | +73.41% | Maintains | 10 days ago |
Nurix Therapeutics IncNRIX | 19 | Buy | $28.00 | +124.81% | Maintains | 10 days ago |
Replimune Group IncREPL | 17 | Buy | $12.00 | +39.86% | Upgrades | 10 days ago |
Bolt Biotherapeutics IncBOLT | 1 | Buy | $7.00 | +43.74% | Assumes | 17 days ago |
Adc Therapeutics SaADCT | 19 | Buy | $7.00 | +75.00% | Maintains | 21 days ago |
Zymeworks IncZYME | 22 | Buy | $26.00 | +44.04% | Upgrades | 23 days ago |
Karyopharm Therapeutics IncKPTI | 2 | Buy | $15.00 | +179.85% | Upgrades | 24 days ago |
Perspective Therapeutics IncCATX | 5 | Buy | $10.00 | +329.18% | Reiterates | a month ago |
Prelude Therapeutics IncPRLD | 17 | Buy | $5.00 | +259.71% | Reiterates | a month ago |
Nuvation Bio IncNUVB | 15 | Buy | $10.00 | +103.25% | Reiterates | 2 months ago |
Bridgebio Oncology Therapeutics IncBBOT | 1 | Buy | $27.00 | +117.74% | Initiates Coverage On | 2 months ago |
Cullinan Therapeutics IncCGEM | 2 | Buy | $24.00 | +228.32% | Reiterates | 2 months ago |
IMMIX Biopharma IncIMMX | 9 | Buy | $8.00 | +162.30% | Maintains | 2 months ago |
Telix Pharmaceuticals LtdTLX | 2 | Buy | $20.00 | +94.36% | Maintains | 2 months ago |
Biontech SeBNTX | 43 | Buy | $136.00 | +31.49% | Reiterates | 2 months ago |
Onkure Therapeutics IncOKUR | 4 | Buy | $34.00 | +1,033.33% | Reiterates | 2 months ago |
Relay Therapeutics IncRLAY | 21 | Buy | $14.00 | +113.74% | Maintains | 2 months ago |
Bicara Therapeutics IncBCAX | 5 | Buy | $40.00 | +182.89% | Maintains | 2 months ago |
Oric Pharmaceuticals IncORIC | 25 | Buy | $19.00 | +53.47% | Maintains | 3 months ago |
Arrivent Biopharma IncAVBP | 11 | Buy | $42.00 | +129.13% | Maintains | 3 months ago |
Black Diamond Therapeutics IncBDTX | 14 | Buy | $10.00 | +158.40% | Maintains | 3 months ago |
Y Mabs Therapeutics IncYMAB | 15 | Hold | $8.60 | -0.12% | Downgrades | 3 months ago |
Cardiff Oncology IncCRDF | 3 | Buy | $10.00 | +346.43% | Maintains | 3 months ago |
Adicet Bio IncACET | 1 | Buy | $4.00 | +479.71% | Assumes | 3 months ago |
Elicio Therapeutics IncELTX | 8 | Buy | $13.00 | +42.39% | Maintains | 4 months ago |
Enliven Therapeutics IncELVN | 5 | Buy | $48.00 | +159.46% | Maintains | 4 months ago |
Tuhura Biosciences IncHURA | 3 | Buy | $12.00 | +380.00% | Reiterates | 6 months ago |
Revolution Medicines IncRVMD | 18 | Buy | $72.00 | +21.33% | Maintains | 6 months ago |
Springworks Therapeutics IncSWTX | 29 | Hold | $47.00 | +0.02% | Downgrades | 6 months ago |
Tango Therapeutics IncTNGX | 12 | Buy | $13.00 | +73.10% | Reiterates | 7 months ago |
Pmv Pharmaceuticals IncPMVP | 11 | Buy | $5.00 | +281.68% | Reiterates | 8 months ago |
Allogene Therapeutics IncALLO | 14 | Buy | $8.00 | +620.72% | Maintains | 8 months ago |
Cargo Therapeutics IncCRGX | 3 | Buy | $33.00 | +638.26% | Reiterates | a year ago |
Igm Biosciences IncIGMS | 13 | Hold | $11.00 | N/A | Maintains | a year ago |
Kronos Bio IncKRON | 10 | Buy | $2.25 | N/A | Reiterates | a year ago |
Omega Therapeutics IncOMGAQ | 9 | Buy | $12.00 | N/A | Reiterates | a year ago |
Apollomics IncAPLM | 5 | Buy | $200.00 | N/A | Maintains | a year ago |
Viracta Therapeutics IncVIRX | 8 | Buy | $4.00 | N/A | Reiterates | 2 years ago |
Effector Therapeutics IncEFTR | 3 | Buy | $24.00 | N/A | Reiterates | 2 years ago |
Calidi Biotherapeutics IncCLDI | 2 | Buy | $240.00 | N/A | Maintains | 2 years ago |
Kineta IncKANT | 4 | Buy | $8.00 | N/A | Reiterates | 2 years ago |
Alphaton Capital CorpATON | 5 | Buy | $120.00 | N/A | Maintains | 2 years ago |
Whitehawk Therapeutics IncWHWK | 9 | Buy | $36.00 | N/A | Maintains | 2 years ago |
Kinnate Biopharma IncKNTE | 6 | Buy | $24.00 | N/A | Reiterates | 2 years ago |
Gt Biopharma IncGTBP | 6 | Buy | $150.00 | N/A | Reiterates | 2 years ago |
Atara Biotherapeutics IncATRA | 8 | Buy | $700.00 | N/A | Maintains | 2 years ago |
Imagenebio IncIMA | 4 | Buy | $264.00 | N/A | Reiterates | 3 years ago |
Tcr2 Therapeutics IncTCRR | 4 | Buy | $13.00 | N/A | Maintains | 3 years ago |
Neurogene IncNGNE | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Forma Therapeutics Holdings IncFMTX | 2 | Hold | $20.00 | N/A | Downgrades | 3 years ago |
Turning Point Therapeutics IncTPTX | 6 | Hold | $76.00 | N/A | Downgrades | 3 years ago |
Cytomx Therapeutics IncCTMX | 1 | Buy | $11.00 | N/A | Maintains | 4 years ago |
Nucana PLCNCNA | 7 | Buy | $45,000.00 | N/A | Maintains | 4 years ago |
Molecular Partners AgMOLN | 1 | Buy | $25.00 | N/A | Assumes | 4 years ago |
Autolus Therapeutics PLCAUTL | 1 | Buy | $13.00 | N/A | Maintains | 5 years ago |
Immunomedics IncIMMU | 4 | Hold | $88.00 | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.